title: Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
authors.forename: L
authors.initials: L
authors.lastname: Boudin
authors.forename: A
authors.initials: A
authors.lastname: Gonçalves
authors.forename: R
authors.initials: R
authors.lastname: Sabatier
authors.forename: J
authors.initials: J
authors.lastname: Moretta
authors.forename: P
authors.initials: P
authors.lastname: Sfumato
authors.forename: P
authors.initials: P
authors.lastname: Asseeva
authors.forename: D
authors.initials: D
authors.lastname: Livon
authors.forename: F
authors.initials: F
authors.lastname: Bertucci
authors.forename: J-M
authors.initials: JM
authors.lastname: Extra
authors.forename: C
authors.initials: C
authors.lastname: Tarpin
authors.forename: G
authors.initials: G
authors.lastname: Houvenaeghel
authors.forename: E
authors.initials: E
authors.lastname: Lambaudie
authors.forename: A
authors.initials: A
authors.lastname: Tallet
authors.forename: M
authors.initials: M
authors.lastname: Resbeut
authors.forename: H
authors.initials: H
authors.lastname: Sobol
authors.forename: E
authors.initials: E
authors.lastname: Charafe-Jauffret
authors.forename: B
authors.initials: B
authors.lastname: Calmels
authors.forename: C
authors.initials: C
authors.lastname: Lemarie
authors.forename: J-M
authors.initials: JM
authors.lastname: Boher
authors.forename: P
authors.initials: P
authors.lastname: Viens
authors.forename: F
authors.initials: F
authors.lastname: Eisinger
authors.forename: C
authors.initials: C
authors.lastname: Chabannon